HC Wainwright & Co. Maintains Buy on Replimune Group, Raises Price Target to $51
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Robert Burns maintains a Buy rating on Replimune Group (NASDAQ:REPL) and raises the price target from $50 to $51.
June 05, 2023 | 10:21 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. maintains a Buy rating on Replimune Group and raises the price target from $50 to $51.
The news of HC Wainwright & Co. maintaining a Buy rating on Replimune Group and raising the price target from $50 to $51 indicates a positive outlook for the company's stock. This could lead to an increase in investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100